Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Total-Current-Liabilities" stands at 24.85 Billion Hong Kong Dollars as of 06/30/2025, the highest value since 09/30/2023.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Total Current Liabilities" stands at 24.85 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 21.62 percent compared to the value the year prior.
The 1 year change in percent is 21.62.
The 3 year change in percent is 52.78.
The 5 year change in percent is 135.89.
The 10 year change in percent is 447.68.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Current Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Current Liabilities | 280,205,508,085.11 |